Wave Life Sciences (WVE) Enterprise Value Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.93% |
| Dec 31, 2025 | -89.48% |
| Sep 30, 2025 | -10.09% |
| Jun 30, 2025 | -12.06% |
| Mar 31, 2025 | -29.59% |
| Dec 31, 2024 | -26.12% |
| Sep 30, 2024 | -35.89% |
| Jun 30, 2024 | -2.31% |
| Mar 31, 2024 | -6.79% |
| Dec 31, 2023 | -2.79% |
| Sep 30, 2023 | 13.53% |
| Jun 30, 2023 | 7.19% |
| Mar 31, 2023 | -19.74% |
| Dec 31, 2022 | 15.59% |
| Sep 30, 2022 | 11.06% |
| Jun 30, 2022 | 16.33% |
| Mar 31, 2022 | 27.03% |
| Dec 31, 2021 | 4.86% |
| Sep 30, 2021 | 16.19% |
| Jun 30, 2021 | 15.86% |
| Mar 31, 2021 | -10.37% |
| Dec 31, 2020 | -8.99% |
| Sep 30, 2020 | -8.70% |
| Jun 30, 2020 | -3.11% |
| Mar 31, 2020 | 2.26% |
| Dec 31, 2019 | 0.70% |
| Sep 30, 2019 | -7.34% |
| Jun 30, 2019 | -11.64% |
| Mar 31, 2019 | -23.30% |
| Dec 31, 2018 | -2.74% |
| Sep 30, 2018 | -47.17% |
| Jun 30, 2018 | -214.26% |
| Mar 31, 2018 | -116.02% |
| Dec 31, 2017 | -414.23% |
| Sep 30, 2017 | -307.53% |